Thermo Fisher Scientific Inc.. (6/3/09). "Press Release: Thermo Fisher Scientific Thermo Fisher Scientific Releases Watson LIMS 7.4 with TSQ Series LC/MS Connectivity at ASMS 2009. Additional Functionality Includes Incurred Sample Reanalysis Enhancements

	Organisation	Thermo Fisher Scientific Inc. (NYSE: TMO)
	Group	Thermo Fisher (Group)
	Product	Watson LIMS™
	Product 2	TSQ Quantum Access MAX™ triple-stage quadrupole mass spectrometry system

Thermo Fisher Scientific Inc., the world leader in serving science, will introduce new functionality to its latest release of Watson LIMS that brings critical time and cost savings to pharmaceutical companies and contract research organizations (CROs) involved in drug metabolism and pharmacokinetic (DMPK) studies for drug discovery and development. Thermo Scientific Watson LIMS will be showcased at the Thermo Scientific hospitality suite at the Philadelphia Marriott Downtown in Salons G-K during the American Society of Mass Spectrometry (ASMS) conference, which runs from May 31-June 4 in Philadelphia.

Thermo Scientific Watson LIMS (Laboratory Information Management System), purpose-built for bioanalytical applications, now includes a built-in data interchange with the company's TSQ Series mass spectrometers, allowing for direct data acquisition, peak integration and re-integration, storage, archiving and reporting of raw data, all under the control of Watson's centralized Oracle database repository. Watson's connectivity to Thermo Scientific TSQ Series mass spectrometers eliminates time-consuming manual verification of LC/MS data transfers, and provides a single audit trail for QA and the FDA, providing greater workflow efficiencies, time and cost savings.

In addition to Watson's industry-first interface with the LC/MS, the release of Watson 7.4 also simplifies daily workflow for bioanalytical laboratories by delivering enhanced functionality for incurred sample reanalysis (ISR). ISR has become an accepted way to assess the quality of bioanalytical assays and is widely accepted within the pharmaceutical industry and by regulatory agencies. The latest release of Watson LIMS allows researchers to perform incurred sample reanalysis on an individual sample basis, and eliminates the previously required mandatory repeat runs for bioanalytical samples. Watson's new ISR reporting features provide new comparison methods with built-in calculations and greater ease of use by enabling flexible, pre-configured reporting of ISR results using templates, for a truly out-of-the-box user experience. Watson's direct data acquisition from Thermo Scientific TSQ Series LC/MS instruments together with its new incurred sample reanalysis functionality and reporting will deliver time savings to pharmaceutical companies and CROs, allowing them to bring drugs to market faster for less cost.

The strength of this end-to-end solution is unique to Watson-based data processing and reporting, for data that is acquired directly from the TSQ Series LC/MS. This solution delivers greatly enhanced functionality for data security and chain of custody for regulatory compliance, as well as a lower cost of ownership due to the reduced validation burden. Thermo Scientific Watson LIMS is the leading bioanalytical LIMS, and is relied upon by 18 of the top 20 pharmaceutical companies as well as leading CROs worldwide. Watson is a highly specialized, protocol-driven software application designed to support drug metabolism and pharmacokinetic (DMPK) studies in drug discovery and development. Pharmaceutical companies and CROs worldwide that standardize on Thermo Scientific Watson LIMS can count on secure data transmissions, regulatory compliance, reliable audit trails and improved time to market.

For more information about Thermo Scientific Watson LIMS, please visit the Thermo Scientific hospitality suite at the Philadelphia Marriot Downtown in Salons G-K during ASMS 2009. For more information about Thermo Scientific mass spectrometry solutions, please call 1-800-532-4752, e-mail analyze@thermofisher.comor visit www.thermo.com/ms.

Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.

For a full list of all press releases announcing new products at ASMS 2009, please visit www.thermo.com/ASMS.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. The Thermo Scientific brand represents a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit www.thermofisher.com.

Record changed: 2011-11-25

Follow Us!

Top News

Upcoming Events

Associations

Partners

Thermo Fisher Scientific Inc.. (6/3/09). "Press Release: Thermo Fisher Scientific Thermo Fisher Scientific Releases Watson LIMS 7.4 with TSQ Series LC/MS Connectivity at ASMS 2009. Additional Functionality Includes Incurred Sample Reanalysis Enhancements

More documents for Thermo Fisher (Group)